Graphene Oxide as a Carrier for Drug Delivery of Methotrexate | Zendy

Hani Nasser Abdelhamid | Zendy; Hany Kamal | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Graphene Oxide as a Carrier for Drug Delivery of Methotrexate

Author(s) -

Hani Nasser Abdelhamid,

Hany Kamal

Publication year - 2021

Publication title -

biointerface research in applied chemistry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.216

H-Index - 11

ISSN - 2069-5837

DOI - 10.33263/briac116.1472614735

Subject(s) - graphene , drug delivery , cytotoxicity , methotrexate , transmission electron microscopy , drug , drug carrier , nanotechnology , targeted drug delivery , materials science , oxide , scanning electron microscope , nanomaterials , chemistry , pharmacology , medicine , biochemistry , in vitro , immunology , metallurgy , composite material

Nanomaterials, including carbon-based nanoparticles, have been applied as carriers for anticancer drugs. This short communication reported the synthesis, cytotoxicity, and drug delivery of methotrexate using graphene oxide (GO) as a carrier. GO was synthesized following Hummer's method. It was characterized using X-ray diffraction (XRD), transmission electron microscope (TEM), and scanning electron microscope (SEM). Data analysis confirms the synthesis of GO with high crystallinity and lamellae morphology. GO showed a high cytocompatibility toward the human EA.hy926 endothelial cells. GO has been used as a carrier for the anticancer drug; methotrexate. The drug delivery was tested for hepatocellular carcinoma cells (HepG2 cells), human embryonic kidney cells (HEK293A cells), and porcine skin fibroblasts (PEF).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research